Supporting patient groups and continuously improving knowledge in our therapy areas is part of our corporate responsibility.
Our ultimate goal is to discover and develop innovative therapies to improve patients' quality of life.
We specialize in the treatment of life-threatening diseases. Our patients always come first.
We offer programs for patients, families and patient organizations worldwide. They help to improve the quality of medical care.
Welcome to CSL Innovation GmbH, the Research & Development team in Marburg.
We actively promote collaborations and partnerships to bring innovation to patients.
At CSL Behring, we work every day as if someone’s life depends on it, because it does.
CSL Behring's biotherapeutics are manufactured in state-of-the-art facilities under strictly controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
We want you to feel comfortable at CSL.
Get to know us and learn more about people, projects and what happens in the world of CSL Behring.
Information for the press, such as press releases and press contact.
Popular search terms:
CSL Innovation hosted the 37th edition of the "Inventor’s Lab" Hesse
CSL reports 15% profit growth with a full-year net profit of $2.91 billion (1,2).
SMC accepts CSL Behring’s HEMGENIX® (etranacogene dezaparvovec) for use on an interim basis in Scotland as the first single …
A journey on the trail of research at CSL (1/6)
Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene …
NICE recommends CSL Behring’s HEMGENIX® (etranacogene dezaparvovec) as the first single infusion gene therapy for adults wit…
Making democracy tangible and attractive was the motto of the dialogue event Political x Change
Promoting innovation, inspiring young talents − this is CSL's commitment to the Hessian Founder Award 2024
A Testament to Innovation and Collaboration between Germany and Australia.
Americas
Asia Pacific
Middle East
Europe
